Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab

An 89‐year‐old patient with gallbladder neuroendocrine neoplasms (GB‐NENs) and lung cancer metastasis underwent nivolumab monotherapy, resulting in tumor shrinkage. Surgery and adjuvant nivolumab showed efficiency despite low expression of PD‐L1.

Detalles Bibliográficos
Autores principales: Kanda, Shinichiro, Hiyama, Kazuhiro, Kirino, Izumi, Fukui, Yasuo, Terashima, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568049/
https://www.ncbi.nlm.nih.gov/pubmed/37841882
http://dx.doi.org/10.1002/ccr3.8040
_version_ 1785119272376205312
author Kanda, Shinichiro
Hiyama, Kazuhiro
Kirino, Izumi
Fukui, Yasuo
Terashima, Hideo
author_facet Kanda, Shinichiro
Hiyama, Kazuhiro
Kirino, Izumi
Fukui, Yasuo
Terashima, Hideo
author_sort Kanda, Shinichiro
collection PubMed
description An 89‐year‐old patient with gallbladder neuroendocrine neoplasms (GB‐NENs) and lung cancer metastasis underwent nivolumab monotherapy, resulting in tumor shrinkage. Surgery and adjuvant nivolumab showed efficiency despite low expression of PD‐L1.
format Online
Article
Text
id pubmed-10568049
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105680492023-10-13 Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab Kanda, Shinichiro Hiyama, Kazuhiro Kirino, Izumi Fukui, Yasuo Terashima, Hideo Clin Case Rep Case Report An 89‐year‐old patient with gallbladder neuroendocrine neoplasms (GB‐NENs) and lung cancer metastasis underwent nivolumab monotherapy, resulting in tumor shrinkage. Surgery and adjuvant nivolumab showed efficiency despite low expression of PD‐L1. John Wiley and Sons Inc. 2023-10-11 /pmc/articles/PMC10568049/ /pubmed/37841882 http://dx.doi.org/10.1002/ccr3.8040 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kanda, Shinichiro
Hiyama, Kazuhiro
Kirino, Izumi
Fukui, Yasuo
Terashima, Hideo
Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title_full Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title_fullStr Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title_full_unstemmed Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title_short Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
title_sort effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568049/
https://www.ncbi.nlm.nih.gov/pubmed/37841882
http://dx.doi.org/10.1002/ccr3.8040
work_keys_str_mv AT kandashinichiro effectivetreatmentofgallbladderneuroendocrinecarcinomawithnivolumab
AT hiyamakazuhiro effectivetreatmentofgallbladderneuroendocrinecarcinomawithnivolumab
AT kirinoizumi effectivetreatmentofgallbladderneuroendocrinecarcinomawithnivolumab
AT fukuiyasuo effectivetreatmentofgallbladderneuroendocrinecarcinomawithnivolumab
AT terashimahideo effectivetreatmentofgallbladderneuroendocrinecarcinomawithnivolumab

Ejemplares similares